(Q44621159)

4 December 2017

Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease (English)

1 reference

4 December 2017

Lack of Usefulness of Anti-Transglutaminase Antibodies in Assessing Histologic Recovery After Gluten-Free Diet in Celiac Disease (English)

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

22 March 2024

1 reference

Antonio Tursi

1

1 reference

4 December 2017

Giovanni Brandimarte

2

1 reference

4 December 2017

Gian Marco Giorgetti

3

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14564185

22 March 2024

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

http://journals.lww.com/00004836-200311000-00007

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Journal of Clinical Gastroenterology

22 March 2024

published in

1 reference

4 December 2017

37

1 reference

4 December 2017

5

1 reference

4 December 2017

387-391

1 reference

Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition

4 December 2017

1

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

22 March 2024

Celiac sprue

2

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Review article: management of patients with non-responsive coeliac disease

22 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Malignancy in coeliac disease--effect of a gluten free diet

22 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice

22 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease

22 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

IgA antigliadin antibodies and persistence of jejunal lesions in adult coeliac disease.

22 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease

22 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Reliability of immunologic markers of celiac sprue in the assessment of mucosal recovery after gluten withdrawal

22 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Is human umbilical cord the most suitable substrate for the detection of endomysium antibodies in the screening and follow-up of coeliac disease?

22 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Sorbitol H2-breath test versus anti-endomysium antibodies to assess histological recovery after gluten-free diet in coeliac disease

22 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

The Italian journal of gastroenterology

22 March 2024

13

26

279

Valentini

1994

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Identification of tissue transglutaminase as the autoantigen of celiac disease

22 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Autoantibodies to tissue transglutaminase as predictors of celiac disease

22 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG.

22 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease

22 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

The use of serum tTG-ab assay in patients on gluten-free diet as a measure of dietetic compliance

22 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

The histopathology of coeliac disease

22 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue')

22 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Serological markers for coeliac disease: is it time to change?

22 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery

22 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease

22 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease

22 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00004836-200311000-00007

22 March 2024

Identifiers

1 reference

4 December 2017

1 reference